iluminage, a Unilever brand, partnered with EPAM Continuum to bring clinical skin care into the home
iluminage: Skin Smoothing Laser
The company envisioned a handheld laser that women could use safely and effectively to treat facial lines and wrinkles.
It’s clear to anyone who flips through an issue of Cosmopolitan or wanders the beauty section of Nordstrom: The market for products that effectively reduce signs of aging is a burgeoning one. The most effective anti-aging techniques—those that remove unwanted hair, age spots, or facial lines and wrinkles—usually involve the use of a medical laser. Traditionally, such laser treatments were only accessible in a clinician’s office and required a trained professional to administer. Not only are these procedures expensive, but they’re also inconvenient to schedule and attend regularly. Many women find it difficult to stick with the treatments long enough to see real results.
Assembling an expansive team of mechanical and electrical engineers, as well as industrial and digital designers, EPAM Continuum made this vision a reality.
FDA-approved for in-home use, the iluminage Skin Smoothing Laser has been clinically proven to reduce lines and wrinkles around the eyes and mouth. As the world’s first connected beauty device, the Skin Smoothing Laser establishes a new market category at the intersection of consumer electronics and women’s cosmetics. It also gives women around the world access to professional-quality beauty treatments from their own home.
When it launched in the summer of 2014, the Skin Smoothing Laser garnered notable media attention for both its efficacy and design. The device has been mentioned by publications including W Magazine, Shape, Cosmopolitan, Elle, Women’s Health, Allure, and Glamour, amongst others.
The Skin Smoothing Laser is sold online, as well as at Bergdorf Goodman, Sephora, and Nordstrom.
You can find the original case study from EPAM Continuum here.
GET IN TOUCH
Hi! We’d love to hear from you.
Are you ready to design the business models of tomorrow?